Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory/Relapsed Autoimmune Hemolytic Anemia”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Early research (Phase 1)Not Yet RecruitingNCT07287930
What this trial is testing

YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07453368
What this trial is testing

Orelabrutinib in the Treatment of Relapsed/Refractory AIHA

Who this might be right for
Autoimmune Hemolytic Anemia (AIHA)
Peking Union Medical College Hospital 50
Very early researchLooking for participantsNCT07205315
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Who this might be right for
B-cell Acute Lymphoblastic Leukemia (B-ALL)Chronic Lymphocytic Leukemia (CLL)B-cell Non-Hodgkin's Lymphoma (B-NHL)+1 more
Grit Biotechnology 28
Not applicableNot Yet RecruitingNCT07149818
What this trial is testing

A Single-arm Phase 2 Prospective Clinical Study of Linprixel in the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Peking Union Medical College Hospital 22
Early research (Phase 1)Study completedNCT07075484
What this trial is testing

YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
China Immunotech (Beijing) Biotechnology Co., Ltd. 7
Early research (Phase 1)Not Yet RecruitingNCT07453836
What this trial is testing

Research on YTS109 Cell in Patients With Recurrent/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
China Immunotech (Beijing) Biotechnology Co., Ltd. 13
Early research (Phase 1)UnknownNCT06212154
What this trial is testing

CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy

Who this might be right for
Autoimmune Hemolytic AnemiaCD19 CAR-T Cell Infusion
Institute of Hematology & Blood Diseases Hospital, China 13
Testing effectiveness (Phase 2)UnknownNCT06021977
What this trial is testing

The Safety and Efficacy of Zanubrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Who this might be right for
Refractory/Relapsed Autoimmune Hemolytic Anemia
Institute of Hematology & Blood Diseases Hospital, China 33
Testing effectiveness (Phase 2)Looking for participantsNCT07175493
What this trial is testing

CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia

Who this might be right for
Autoimmune CytopeniaImmune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia+1 more
Keymed Biosciences Co.Ltd 158
Early research (Phase 1)Not Yet RecruitingNCT06770504
What this trial is testing

YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic AnemiaAnti-CD19 STAR T-cell TherapyFailure ≥3 Lines of Therapies
Institute of Hematology & Blood Diseases Hospital, China 7
Early research (Phase 1)Study completedNCT05004259
What this trial is testing

The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune Antibody Mediated Hemolytic Anemia

Who this might be right for
Hemolytic Anemia
Dartmouth-Hitchcock Medical Center 2
Early research (Phase 1)Not Yet RecruitingNCT07585071
What this trial is testing

IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic AnemiaRelapsed/Refractory
Institute of Hematology & Blood Diseases Hospital, China 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07190261
What this trial is testing

A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Autoimmune Hemolytic Anemia
Bing Han 3
Very early researchNot Yet RecruitingNCT06920446
What this trial is testing

UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed / Refractory Autoimmune Hemolytic Anemia
Zhejiang University 18
Early research (Phase 1)Ended earlyNCT05676697
What this trial is testing

PI3K Delta Inhibitor in Relapsed / Refractory Autoimmune Hemolytic Anemia Patients After Receiving Two or More Lines of Therapy

Who this might be right for
Autoimmune Hemolytic AnemiaFailure of Two Rounds of Treatment
Institute of Hematology & Blood Diseases Hospital, China 4
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324889
What this trial is testing

An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Yihao Wang 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04398459
What this trial is testing

The Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic Anemia

Who this might be right for
Refractory/Relapsed Autoimmune Hemolytic Anemia
Institute of Hematology & Blood Diseases Hospital, China 18
Not applicableLooking for participantsNCT05925023
What this trial is testing

Sirolimus in the Treatment of Refractory/Relapsed wAIHA

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Peking Union Medical College Hospital 22
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Early research (Phase 1)Not Yet RecruitingNCT06978738
What this trial is testing

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusAutoimmune Hemolytic AnemiaMyasthenia Gravis+4 more
Changzhou No.2 People's Hospital 18
Load More Results